• Explore /
  • Poster
  • / INTACT: Phase III randomized trial of concurrent chemoradiotherapy with or without atezolizumab in localized muscle invasive bladder cancer<span style="color: #1a1a1a; font-family: Helvetica; font-size: X-large;" size="5" color="#1a1a1a" face="helvetica"></span>—SWOG/NRG1806.

INTACT: Phase III randomized trial of concurrent chemoradiotherapy with or without atezolizumab in localized muscle invasive bladder cancer—SWOG/NRG1806.

Abstract Poster

Authors

null

Parminder Singh

Mayo Clinic Arizona, Phoenix, AZ

Parminder Singh , Cathy Tangen , Jason A. Efstathiou , Seth P. Lerner , Sameer G. Jhavar , Noah M. Hahn , Brian Addis Costello , Srikala S. Sridhar , Weliang Du , Joshua J. Meeks , Bishoy Morris Faltas , Petros Grivas , Felix Y Feng , Ronald C. Chen , Alicia K. Morgans , Amit Gupta , Richard Carlton Bangs , Kathryn A. Winter , Nicholas J. Vogelzang , Ian Murchie Thompson Jr.

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03775265

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr TPS586)

Abstract #

TPS586

Poster Bd #

N4

Abstract Disclosures

Similar Posters

First Author: Shilpa Gupta

First Author: Rebecca Dent

First Author: Amarnath Challapalli

First Author: Zev A. Wainberg